|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/10/24 Processa Pharmaceuticals, Inc. 10-Q 3/31/24 47:3.2M M2 Compliance LLC/FA
4/29/24 Processa Pharmaceuticals, Inc. DEFA14A 1:994K M2 Compliance LLC/FA
4/29/24 Processa Pharmaceuticals, Inc. DEF 14A 4/29/24 1:803K M2 Compliance LLC/FA
4/12/24 Young David 4 Dir.,Off.² 1:8K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
4/12/24 Stanker James H 4 Officer² 1:7K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
4/12/24 Lin Patrick 4 Officer² 1:7K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
4/12/24 Bigora Sian 4 Officer² 1:7K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
4/12/24 Guy Wendy 4 Officer² 1:7K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
4/11/24 Processa Pharmaceuticals, Inc. 8-K:7,9 4/11/24 12:2M M2 Compliance LLC/FA
4/4/24 Processa Pharmaceuticals, Inc. 8-K:7,9 4/3/24 11:7.2M M2 Compliance LLC/FA
3/29/24 Processa Pharmaceuticals, Inc. 10-K 12/31/23 72:23M M2 Compliance LLC/FA
2/21/24 Processa Pharmaceuticals, Inc. 8-K:7,9 2/20/24 11:7.2M M2 Compliance LLC/FA
2/8/24 Young David 4 Dir.,Off.² 1:5K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
2/7/24 Young David 4 Dir.,Off.² 1:6K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
2/6/24 Processa Pharmaceuticals, Inc. 8-K:8,9 2/6/24 11:224K M2 Compliance LLC/FA
2/1/24 Lin Patrick 4 Officer² 1:5K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
1/31/24 Ng George K 4 Dir.,Off.² 1:5K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
1/31/24 Yorke Justin W 4 Director² 1:5K Processa Pharmaceuticals, Inc. Foley & Lardner/FA
1/30/24 Processa Pharmaceuticals, Inc. 8-K:1,7,9 1/26/24 15:995K M2 Compliance LLC/FA
1/29/24 Processa Pharmaceuticals, Inc. 424B4 1:658K M2 Compliance LLC/FA
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 10-Q | Quarterly Report — Form 10-Q. | | 424B4 | Prospectus – Info Previously Omitted & New Facts or Events. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | DEFA14A | Definitive Additional Proxy Soliciting Material — Schedule 14A. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|